![]() | |
Company type | Public limited company |
---|---|
ISIN | GB00BMX86B70 |
Industry | |
Predecessors | |
Founded | 18 July 2022 |
Headquarters | Weybridge, England, United Kingdom |
Area served | Worldwide |
Key people |
|
Products |
|
Brands | |
Revenue | ![]() |
![]() | |
![]() | |
Total assets | ![]() |
Total equity | ![]() |
Number of employees | 24,000 (2023)[2] |
Website | www |
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England.[3] It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins.[4] The company was projected to be a global leader in over the counter medicines with a 7.3 percent market share in 2022.[5]
Haleon was established on 18 July 2022 as a corporate spin-off from GSK.[6]
Sir David Lewis is chairman, with Brian McNamara as CEO.[7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020.[5]